Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease

Summary: Steatotic liver disease (SLD) is the leading cause of chronic liver disease in Europe, with liver fibrosis representing the strongest predictor of liver-related outcomes and an important contributor to cardiometabolic risk. This Series paper examines diagnostic innovation and models of care...

Descripción completa

Detalles Bibliográficos

Autores principales:	Nicola Pugliese, Trenton M. White, Paul N. Brennan, Silvana Pannain, Hannes Hagström, Maurice Michel, Lisa Rice-Duek, Giovanni Targher, Cyrielle Caussy, John F. Dillon, Frank Tacke, Christopher J. Kopka, Giada Sebastiani, Jerome Boursier, Emmanuel A. Tsochatzis, Willem Pieter Brouwer, Giovanni Guaraldi, Roberto Vettor, Maja Thiele, Michael Roden, Norbert Stefan, Helen Jarvis, Pere Gines, Jörn M. Schattenberg, Elisa Pose, Stefan Buttigieg, Christopher D. Byrne, Jeffrey V. Lazarus
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2026-06-01
Colección:	The Lancet Regional Health. Europe
Materias:	MASLD metALD Non-invasive tests Diagnostic innovation Fibrosis detection Risk stratification
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2666776226001341
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!